The House proposed a patent reform bill stating that failure to disclose the "best mode" cannot be used to invalidate or cancel a patent, which might allow biotechs stronger protection of trade secrets.

The Supreme Court ruled in Stanford v. Roche that, under the Bayh-Dole Act, federal funding of research does not automatically void an inventor's patent rights in favor of the federal contractor.